Recorded Chinese product: 联苯双酯胶囊联苯双酯胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 重庆科瑞制药(集团)有限公司Chinese legal name: 重庆科瑞制药(集团有限公司)
主要成分Active Ingredients
- 联苯双酯Lianben Shuangzhi
药物知识说明
联苯双酯是一种在国家药监局注册认定的药品。该药品含有联苯双酯-7e6fe849等成分。
该药品关联的活性成分包括:联苯双酯Lianben Shuangzhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:重庆科瑞制药(集团)有限公司Chinese legal name: 重庆科瑞制药(集团有限公司)。
您可以探索含有相同成分的其他药品:联苯双酯-7e6fe849成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 联苯双酯胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 联苯双酯Lianben Shuangzhi.
Manufacturers recorded for this product: 重庆科瑞制药(集团)有限公司Chinese legal name: 重庆科瑞制药(集团有限公司).
Explore other medicines containing the same ingredient: 联苯双酯 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 联苯双酯胶囊Recorded Chinese product: 联苯双酯胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 25mg25 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 重庆科瑞制药(集团)有限公司Chinese legal name: 重庆科瑞制药(集团有限公司)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H50021741
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H50021741
Manufacturer
Chinese legal name: 重庆科瑞制药(集团)有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H50021741
生产企业
重庆科瑞制药(集团)有限公司(国产)
适应症
适用于迁延型肝炎和长期单项丙氨酸氨基转移酶异常者。
用法用量
口服给药:|1.滴丸:每次7.5mg,每天3次,必要时每次9~15mg,每天3次,连用3个月。ALT正常后减为每次7.5mg,每天3次,用3个月。|2.片剂:开始每次25~50mg,每天3次;ALT正常后减为每次25mg,每天3次。疗程同滴丸。
不良反应
本药不良反应少见而轻微,对造血系统无不良影响。|1.偶可引起胆固醇增高。|2.个别患者服药后有轻度恶心、口干、胃部不适、皮疹等反应,但一般不影响治疗。|3.有报道9例病毒性肝炎患者服用本药后出现黄疸、肝功能损害和症状加重,但停药后症状迅速消失,肝功能恢复正常。应引起注意。
禁忌
肝硬化患者。
注意事项
慎用:慢性活动性肝炎。
贮藏
密封,置阴凉处。
规格
25mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.